PureTech Health Shares Outstanding 2019-2024 | PRTC

PureTech Health shares outstanding from 2019 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

PureTech Health Shares Outstanding 2019-2024 | PRTC

PureTech Health shares outstanding from 2019 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$222.8B
Amgen (AMGN)$162B
Gilead Sciences (GILD)$140.6B
Vertex Pharmaceuticals (VRTX)$118.3B
Bristol Myers Squibb (BMY)$96.7B
CSL (CSLLY)$85.2B
GSK (GSK)$76.5B
Regeneron Pharmaceuticals (REGN)$60.3B
Alnylam Pharmaceuticals (ALNY)$42.3B
Argenex SE (ARGX)$36.4B
BioNTech SE (BNTX)$27.1B
Royalty Pharma (RPRX)$20.8B
Insmed (INSM)$19.3B
Biogen (BIIB)$18.9B
Illumina (ILMN)$17.4B
Genmab (GNMSF)$15.2B
Genmab (GMAB)$14.8B
Incyte (INCY)$13.6B
Moderna (MRNA)$13.1B
Exelixis (EXEL)$12.1B
QIAGEN (QGEN)$11.3B
BioMarin Pharmaceutical (BMRN)$11.1B
Swedish Orphan Biovitrum (BIOVF)$10.6B
Ascendis Pharma (ASND)$10B
Bio-Techne Corp (TECH)$9.2B
Exact Sciences (EXAS)$9.1B
Verona Pharma American Depositary Share (VRNA)$8.9B
Blueprint Medicines (BPMC)$8.3B
Roivant Sciences (ROIV)$7.7B
Legend Biotech (LEGN)$7.6B